A couple of thoughts on the current trading activity and depression of the stock price.

As someone pointed out, volumes are still low in the total scheme of things but high enough to depress the stock price in the current environment.  There are undoubtedly some that got into this stock hoping it would skyrocket in a way that would change their fortunes.  But, not every shareholder has deep pockets and can afford to wait.  I find it noteworthy that these larger than normal volumes are taking place just prior to month end.  Some people may have lost their job and need to pay the rent or mortgage and, most importantly, put food on the table.  So, the RVX dream may have to take a backseat. 

Secondly, I don’t think this level of trading activity can be viewed as a judgement on the science either.  The BETonMACE trial, although not reaching its primary endpoint, did reveal some very noteworthy positives, some of which led to being granted a BTD by the FDA.  So while it does seem likely that the full potential of ABL may not be realized for another year or two (and this Covid-19 pandemic certainly isn’t helpful) it doesn’t mean that there isn’t a lot of potential here, even though the SP is currently less than $1.  Being invested in a stock like this requires a LOT of patience and if you have that, or have any left, then in the long run you’ll still likely do well simply because, arguably, proof of concept in epigenetic science has now been determined. 

The big question is when it will pay off.